We found that A3G had no hypermutation activity toward eukaryotic DNA by the detection of the hypermutation of K-Ras DNA in eukaryotic cells overexpressing A3G (data not shown), indicating that the role of A3G in pancreatic cancer malignancy is via a novel mechanism independent of deaminase activity. The gene discussed is KRAS; the disease is pancreatic neoplasm.